May 22, 2025 New FDA-Approved Topical Foam for Scalp Psoriasis The FDA has approved roflumilast (ZORYVE) foam 0.3% for once-daily treatment of plaque psoriasis in patients aged 12 and older, including hard-to-treat scalp and body areas.. Conexiant
April 30, 2025 AACR 2025: Topical BRAF Inhibitor Under Study for Managing Acneiform Rash The ASCO Post
April 29, 2025 AACR 2025: Pretrained AI Models Could Help Accurately Diagnose Nonmelanoma Skin Cancers in Resource-Limited Settings The ASCO Post
May 27, 2021 Study Finds Adjuvant Immunotherapy of Benefit to Patients With Stage IIB/C Melanoma The ASCO Post
April 26, 2024 New Social Media Trend Involving Freckle Tattoos May Conceal Early Signs of Skin Cancer Conexiant